College of Chemistry and Molecular Sciences, Wuhan University , Wuhan, Hubei 430072, P. R. China.
Department of Chemistry, South University of Science and Technology of China , Shenzhen, Guangdong 518055, P. R. China.
Org Lett. 2017 May 19;19(10):2548-2551. doi: 10.1021/acs.orglett.7b00844. Epub 2017 Apr 27.
The iridium-f-amphox-catalyzed asymmetric hydrogenation of racemic α-amino β-unfunctionalized ketones proceeds via a DKR (dynamic kinetic resolution) process for the construction of various chiral N,N-disubstituted α-amino β-unfunctionalized alcohols in quantitative yields with excellent enantioselectivities and diastereoselectivities (all products >99% ee and >99:1 dr, TON up to 100 000). Importantly, this catalytic asymmetric hydrogenation with a DKR process provided a highly efficient and powerful synthetic strategy for the preparation of key chiral intermediates of the preclinical antitumor agent (S,S)-R116010.
铱-酰胺配合物催化外消旋 α-氨基 β-未官能化酮的不对称氢化是通过 DKR(动态动力学拆分)过程进行的,可定量收率、高对映选择性和非对映选择性地构建各种手性 N,N-二取代的 α-氨基 β-未官能化醇(所有产物的ee 值>99%,dr 值>99:1,TON 高达 100000)。重要的是,这种具有 DKR 过程的催化不对称氢化为临床前抗肿瘤剂 (S,S)-R116010 的关键手性中间体的制备提供了一种高效、强大的合成策略。